[Other] Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1

ziiiizuuu Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-09-07 05:50

Reward20points

journal：Annals of Internal Medicine

Authors：Amy E. Colson; Gordon E. Crofoot; Peter J. Ruane; Moti N. Ramgopal; Alexandra W. Dretler; Ronald G. Nahass; Gary I. Sinclair; Mezgebe Berhe; Afsoon Roberts; Shauna Applin; Cynthia Brinson; Dushyantha Jayaweera; Kimberly A. Workowski; Fadi Shihadeh; Shan-Yu Liu; Stephanie Klopfer; Cyril Llamoso; Sharline Madera; Hadas Dvory-Sobol; Martin S. Rhee; Elizabeth G. Rhee; Jared M. Baeten; Joseph J. Eron

Published date：2026-2-

DOI：10.7326/annals-25-01939

PDF link：https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-25-01939

Article link：https://doi.org/10.7326/annals-25-01939

Article Source：American College of Physicians。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

ziiiizuuu Lv.2

Junior Member

post
reply
points
20

[Other] Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1